In the latest trading session, 0.83 million Bausch Health Companies Inc (NYSE:BHC) shares changed hands as the company’s beta touched 0.73. With the company’s most recent per share price at $6.31 changing hands around $0.06 or 0.93% at last look, the market valuation stands at $2.32B. BHC’s current price is a discount, trading about -81.62% off its 52-week high of $11.46. The share price had its 52-week low at $3.96, which suggests the last value was 37.24% up since then. When we look at Bausch Health Companies Inc’s average trading volume, we note the 10-day average is 3.2 million shares, with the 3-month average coming to 3.68 million.
Analysts gave the Bausch Health Companies Inc (BHC) stock a consensus recommendation rating of Hold, calculated at a mean rating of 3.14. If we narrow down to specifics, the data shows that 0 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended BHC as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Bausch Health Companies Inc’s EPS for the current quarter is expected to be 1.04.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bausch Health Companies Inc (NYSE:BHC) trade information
Instantly BHC is in green as seen in intraday trades today. With action 1.26%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -21.34%, with the 5-day performance at 1.26% in the green. However, in the 30-day time frame, Bausch Health Companies Inc (NYSE:BHC) is 16.60% up. Looking at the short shares, we see there were 19.98 million shares sold at short interest cover period of 3.6 days.
The consensus price target for the stock as assigned by Wall Street analysts is 9, meaning bulls need an upside of 29.89% from its recent market value. According to analyst projections, BHC’s forecast low is 7 with 16 as the target high. To hit the forecast high, the stock’s price needs a -153.57% plunge from its current level, while the stock would need to soar -10.94% for it to hit the projected low.
Bausch Health Companies Inc (BHC) estimates and forecasts
Data shows that the Bausch Health Companies Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -31.36% over the past 6 months, a 3.44% in annual growth rate that is considerably lower than the industry average of 21.60%. Year-over-year growth is forecast to reach 8.30% up from the last financial year.
Consensus estimates given by 6 financial analysts project the company’s revenue in the current quarter to hit an average of 2.42B. 6 analysts are of the opinion that Bausch Health Companies Inc’s revenue for the current quarter will be 2.52B. The company’s revenue for the corresponding quarters a year ago was 2.15B and 2.41B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 12.40%. The estimates for the next quarter sales put growth at 4.60%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 32.76%. The 2024 estimates are for Bausch Health Companies Inc earnings to increase by 4.10%, but the outlook for the next 5-year period is at 2.60% per year.
BHC Dividends
Bausch Health Companies Inc is expected to release its next quarterly earnings report on 2024-Oct-31. During the past 5 years, the average dividend yield was 6.52 per year.
Bausch Health Companies Inc (NYSE:BHC)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.28% of Bausch Health Companies Inc shares while 78.98% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 89.03%. There are 78.98% institutions holding the Bausch Health Companies Inc stock share, with ICAHN CARL C the top institutional holder. As of 2024-06-30, the company held 9.466% of the shares, roughly 34.72 million BHC shares worth $242.01 million.
PAULSON & CO. INC. holds the second largest percentage of outstanding shares, with 7.208% or 26.44 million shares worth $184.28 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jun 30, 2024 were Franklin Custodian Funds-Income Fund and Vanguard International Stock Index-Total Intl Stock Indx. With 10.27 shares estimated at $64.49 million under it, the former controlled 2.84% of total outstanding shares. On the other hand, Vanguard International Stock Index-Total Intl Stock Indx held about 1.21% of the shares, roughly 4.38 shares worth around $27.5 million.
